Programs

SUN bioscience is supporting multiple clinical pilots that aim at using organoids for clinical diagnostics.

Cystic Fibrosis

SUN bioscience supports the development of a clinically approved organoid-driven diagnostic test for Cystic Fibrosis that will help doctors tailor the medication plan to each of their patients.

See More v

Perfusable Organoids

SUN bioscience is currently developing perfusable organoid systems for applications ranging from toxicity tests to epithelial barrier modelling.

Colorectal cancer

Gri3D® is used in the development of novel relevant colorectal organoids that recapitulate as closely as possible native tumors in order to identify new treatments for the third most common cancer worldwide.

These programs have received support by the following funding agencies: